Hafrun Fridriksdottir

Hafrun Fridriksdottir currently serves as President of the Generic Business at Hikma Pharmaceuticals, a position held since April 2024. Additionally, Hafrun is a Strategic Advisor at Lupin Pharmaceuticals and LTS Advisory Limited, as well as a Board Member at EpiEndo Pharmaceuticals and Remedica. Previously, Hafrun held the role of Chief Operating Officer at Alvotech and served as Executive Vice President at Teva Pharmaceuticals from September 2016 to August 2022. Earlier career achievements include positions such as Senior Vice President of R&D at Allergan and SVP R&D at Actavis. Hafrun's foundational education includes a PhD in Pharmacy and a Master of Science in Pharmacy from Háskóli Íslands.